ssRNA viruses |
|
|
|
Influenza A |
Orthomyxoviridae |
Inhibits viral budding from cell membrane |
8, 11
|
Hepatitis C |
Flaviviridae |
Inhibits formation of replication complex by promoting degradation of viral protein NS5A |
12–14
|
Dengue (type II) |
Flaviviridae |
Inhibits viral genome replication interacting with viral protein NS3 |
3, 15–17
|
Tick-borne encephalitis |
Flaviviridae |
Promotes degradation of viral protein NS3 through proteasome-mediated pathway |
18–20
|
Zika |
Flaviviridae |
Promotes degradation of viral protein NS3 through proteasome-mediated pathway |
3, 17, 18, 21, 22
|
West Nile |
Flaviviridae |
Regulates viral replication; exact molecular mechanism not known |
3, 15, 17
|
Chikungunya |
Togaviridae |
Reduces expression of viral RNA helicase protein NSP2; exact mechanism not known |
23, 24
|
Sindbis |
Togaviridae |
Regulates viral replication; exact mechanism not known |
25, 26
|
Sendai |
Paramyxoviridae |
Controls viral replication; exact mechanism not known |
10, 27
|
Vesicular stomatitis virus |
Rhabdoviridae |
Inhibits viral replication in IFN-independent pathway |
28–30
|
Classical swine fever |
Flaviviridae |
Inhibits CSFV replication by interacting with viral nonstructural protein NS5A and E2 |
31, 32
|
Viral hemorrhagic septicemia |
Rhabdoviridae |
Inhibits RNA transcription and replication |
6, 33
|
Measles |
Paramyxoviridae |
Inhibits viral release |
34 |
Newcastle disease |
Paramyxoviridae |
Regulates viral replication, potentially by interacting with viral matrix proteins, involved in viral assembly and budding |
29, 31, 35
|
Enterovirus A71 |
Picornaviridae |
Inhibits viral replication by interacting with viral protein 2C, important for membrane binding of virus. |
36 |
Lymphocytic choriomeningitis |
Arenaviridae |
Exact mechanism not known |
37 |
Junin mammarena |
Arenaviridae |
Impairs viral budding by perturbing lipid droplet morphogenesis and mis localization of viral glycoproteins |
38 |
Rabies |
Rhabdoviridae |
Impairs viral budding by disrupting cholesterol/sphingomyelin synthesis and up-regulating TLR4 |
28, 39
|
Porcine reproductive and respiratory syndrome |
Arteriviridae |
Impairs early steps of viral entry and genome replication and translation by interacting with viral protein N |
40 |
Respiratory syncytial |
Pneumoviridae |
Impairs viral transmission by inhibiting virus filament formation |
41 |
Bunyamwera |
Peri Bunyaviridae |
Inhibits viral replication; exact mechanism not known |
42 |
Rhino |
Picornaviridae |
May inhibit viral replication; exact mechanism not known |
43 |
Yellow fever |
Flaviviridae |
May inhibit viral replication; exact mechanism not known |
44 |
Retroviruses |
|
|
|
Human immunodeficiency |
Retroviridae |
Inhibits viral egress by perturbing lipid raft formation |
45, 46
|
Equine infectious anemia |
Retroviridae |
Reduces viral budding by interacting with viral envelope proteins |
47 |
dsDNA viruses |
|
|
|
Human cytomegalovirus |
Herpesviridae |
Co-opted by the virus to inhibit β-oxidation of fatty acids by mitochondrial trifunctional protein |
6, 7, 48–50
|
Herpes simplex 1 |
Herpesviridae |
Inhibits viral replication by interacting with viral glycoprotein D, found in the virion envelope |
51, 52
|
Singaporean grouper iridovirus |
Iridoviridae |
Restricts viral replication by up-regulating interferon and inflammatory response; exact mechanism not known |
53 |